Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JETALS: Ultra-high Dose Methylcobalamin for Early-stage ALS
NCT03548311Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2017
- Primary completion
- Feb 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of methylcobalamin in amyotrophic lateral sclerosis (ALS), sponsored by Eisai Co., Ltd.. Started Nov 2017; status: completed.
02
Drugs
methylcobalamin
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT03548311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03548311.